DOSSIER · 13F Holders · Q2 2025
CALIDI BIOTHERAPEUTICS INC
2 institutions still hold CALIDI BIOTHERAPEUTICS INC as of Q2 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 320703309·2 13F holders·last filed Jun 30, 2025
AI Holders Summary · Q2 2025
2 institutions reported CALIDI BIOTHERAPEUTICS INC in Q2 2025. Grassi Investment Management leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.